4//SEC Filing
HI TECH PHARMACAL CO INC 4
Accession 0001566028-13-000016
CIK 0000887497operating
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 12:41 PM ET
Size
9.5 KB
Accession
0001566028-13-000016
Insider Transaction Report
Form 4
April Gary M
President, HCP Division
Transactions
- Exercise/Conversion
Common Stock
2013-09-30$32.59/sh+3,125$101,844→ 3,125 total - Sale
Common Stock
2013-09-30$43.08/sh−3,125$134,625→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-09-30−3,125→ 9,375 totalExercise: $32.59From: 2013-07-16Exp: 2022-07-16→ Common Stock (3,125 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.07 to $43.09, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
- [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
- [F3]The option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- [F4]Other than the option to acquire 9,375 shares reflected on this form as still held by Mr. April following the reported transaction, Mr. April is also the holder of additional options to acquire 18,125 shares of Hi-Tech common stock (for total options to acquire 27,500 shares still held by Mr. April), which options were granted on various dates, with various exercise prices, exercise dates, and expiration dates.
Documents
Issuer
HI TECH PHARMACAL CO INC
CIK 0000887497
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000887497
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 12:41 PM ET
- Size
- 9.5 KB